Visura: Bericht - SECA
Visura: Bericht - SECA
Visura: Bericht - SECA
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
M&A-Bulletin<br />
Juni 2009<br />
Innovative Technologies<br />
Buyside – Majority stake<br />
or 100% acquisition<br />
Region Switzerland, UK, Austria or Ireland<br />
Titel Swiss entrepreneur looking to acquire<br />
a technology leading SME<br />
Kaufgesuche – Beteiligungen - Investment<br />
Schweiz, Deutschland, Österreich, Lichtenstein<br />
Short description The company is producing innovative, leading technologies in the life science sector<br />
(especially medical technology), the environmental technology or the engineering<br />
/ machinery industry. The company has a premium quality angle and promises<br />
growth beyond 10% per annum.<br />
Turnovercategory<br />
# Employees<br />
(heads)<br />
Pricecategory<br />
The company has an international client base or has the potential to expand beyond<br />
its home base in the near future.<br />
The company is either healthy or in short term financial distress; turnarounds in an<br />
operational sense are of no interest, nor are start-ups and firms that have not<br />
reached a cash flow positive stage for at least 2 consecutive years.<br />
The investor is a private entrepreneur with a long term investment horizon (20–30<br />
years) and the interest to grow the company beyond current horizons assuming a<br />
managerial role. Preference is a succession planning situation.<br />
€20-50m for industry, €10-20m for Medical technology<br />
20-200<br />
subject to negotiation; €10-25m<br />
Engagement Just financial<br />
engagement<br />
Reference Project „Successor“<br />
Contact Marcel Jans<br />
+41 44 444 37 55<br />
marcel.jans@bdo.ch<br />
Just<br />
management<br />
both<br />
Seite 73 / 109
Change language